Course Description
Innovative psychiatric pharmacy services often demonstrate strong clinical value but can be challenging to implement and sustain in real-world practice. This session will introduce the fundamental principles of implementation science, review commonly used frameworks and implementation outcomes, and explore how these concepts can be used to improve medication use and psychiatric pharmacy service delivery. Participants will gain a foundational understanding of implementation science and examine practical examples of its application to clinical services, stewardship initiatives, and educational innovations. Whether launching a new practice model or expanding an existing program, this session will provide valuable insights into translating evidence into sustainable improvements in patient care.
Learning Objectives
- Define key terminology and principles of implementation science relevant to psychiatric pharmacy practice.
- Compare implementation science frameworks and implementation outcomes used in healthcare research and practice.
- Describe implementation science concepts designed to improve medication use or service delivery by psychiatric pharmacists.
Target Audience
If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.
Faculty
View biographical information
Clayton English, PharmD, MS, BCPP, BCGP, FAAPP
Assistant Professor and Assistant Director of Research, Center for Pharmacy Practice Transformation, University of Washington School of Pharmacy
Seattle, WA
Dr. Clayton English is an Assistant Professor of Pharmacy at the University of Washington School of Pharmacy, where he practices in the ambulatory care setting as a psychiatric pharmacist at Harborview Mental Health and Addiction Services in Seattle, Washington, and supports the UW Medicine PGY-2 Psychiatry Residency Program. He serves as the assistant director of research in the Center for Pharmacy Practice Transformation which is embedded in the school of pharmacy. The central focus of his research program and position at the UW is to strengthen the sustainable and scalable delivery of pharmacist-provided mental health services by equipping both specialists and generalist pharmacists with the skills and support needed to deliver accessible, safe, and equitable care. He is board-certified in Psychiatric Pharmacy and Geriatric Pharmacy and is an inaugural fellow of the American Association of Psychiatric Pharmacists. He has been recognized for excellence in teaching and contributions to pharmacy practice, receiving the Award of Excellence in Academic Teaching from the University of Vermont Psychiatry Residency Program in 2012, 2017, and 2019, and being named Vermont Pharmacist of the Year by the Vermont Society of Health-System Pharmacists in 2013.
Dr. English completed both his undergraduate and Doctor of Pharmacy degrees at the University of Connecticut. He holds a masters of science degree in health services research from the University of Washington School of Public Health and he completed his post-doctoral residency training in psychiatric pharmacy at Nova Southeastern University.
Jennifer Bacci, PharmD, MPH, BCACP, FCCP
Endowed Associate Professor in Innovative Pharmacy Practice; Director, Center for Pharmacy Practice Transformation, University of Washington School of Pharmacy
Seattle, WA
Jennifer L. Bacci, PharmD, MPH, BCACP, FCCP, is the Endowed Associate Professor of Innovative Pharmacy Practice at the University of Washington School of Pharmacy and Director of the Center for Pharmacy Practice Transformation. Her research focuses on advancing community pharmacy practice through implementation science, translating evidence-based interventions into sustainable, person-centered care. She partners closely with community organizations to address challenges facing practitioners and patients and strengthen the impact of community-based pharmacy teams.
Dr. Bacci's research spans behavioral health, substance use and harm reduction, community pharmacy practice transformation, and the pharmacy workforce. Her current work includes implementing pharmacist-provided maintenance treatment for opioid use disorder and expanding administration and management of long-acting injectable medications in community pharmacies.
Dr. Bacci is a board-certified ambulatory care pharmacist and Fellow of the American College of Clinical Pharmacy with more than a decade of community pharmacy practice experience. She maintains close connections to practice through leadership roles with ACT Pharmacy Collaborative, a nationwide collaboration to support and facilitate community pharmacy practice transformation efforts; CPESN Washington, a clinically integrated network of independent pharmacies in Washington State; and the Washington State Pharmacy Association. Dr. Bacci completed her PharmD, PGY-1 Community-based Pharmacy Residency, Community Pharmacy Research Fellowship at PittPharmacy.
Course Requirements
To receive ACPE credit for this session, you must:
- Register for this course.
- Review the full content of the activity and reflect upon its teachings.
- Complete the evaluation at the end of the activity.
- Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Continuing Education Credit and Disclosures
Activity Dates: 4/7/2027-4/7/2030
ACPE Contact Hours: 1.0
ACPE Number: 0284-0000-##-###-###-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.
The American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
View AAPP's Disclaimer and Disclosure Declarations
AAPP Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Unlabeled Use Disclosure: Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. The faculty, planners, and American Association of Psychiatric Pharmacists do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
View AAPP's Copyright Statement, Terms of Use, and Policies
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
View AAPP's Privacy Policy. AAPP's Terms of Use and other policies on education programs, resources, toolkits, and other web based content/offerings are available here.
View AAPP's Fair Balance and Integrity Statement
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.